HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

LDL-apheresis in acute anterior ischemic optic neuropathy.

Abstract
Acute anterior ischemic optic neuropathy (AION) is a disabling disease which impairs visual function. Standard treatment is unable to affect the outcome and the visual damage persists. We describe the case of a 64-year-old patient affected by AION, whose only known risk factor was hypercholesterolemia. After a first onset of involvement of the right eye (RE), the patient presented four weeks later with an analogous episode affecting the left eye (LE). Since standard treatment, started at involvement of the RE, had not yielded any beneficial effect, the patient underwent three sessions of LDL apheresis. The scotomatous portion of the visual field reduced even after the first session, there was further improvement after the third, and after six months the condition remained stable. Corrected vision improved from 2/10 to 6/10 after the third session. LDL cholesterol and fibrinogen decresade after the third session from 239 mg/dL to 31 mg/dL and from 289 mg/dL to 92 mg/dL, respectively. In conclusion, thanks to its effect of antagonizing hemorheologic disorders of the ocular microcirculation, LDL apheresis seems to be an efficacious treatment of AION, especially in patients suffering from hypercholesterolemia.
AuthorsA Ramunni, G Giancipoli, A Saracino, S Guerriero, M T Saliani, M C Gentile, C Sborgia, P Coratelli
JournalThe International journal of artificial organs (Int J Artif Organs) Vol. 27 Issue 4 Pg. 337-41 (Apr 2004) ISSN: 0391-3988 [Print] United States
PMID15163068 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Lipoproteins, LDL
Topics
  • Blood Component Removal (methods)
  • Female
  • Follow-Up Studies
  • Humans
  • Hypercholesterolemia (complications, diagnosis, therapy)
  • Lipoproteins, LDL (metabolism)
  • Middle Aged
  • Optic Neuropathy, Ischemic (diagnosis, etiology, therapy)
  • Risk Assessment
  • Severity of Illness Index
  • Treatment Outcome
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: